H.R. 764: Global Health, Empowerment and Rights Act
This bill, known as the Global Health, Empowerment and Rights Act, aims to change specific eligibility criteria for foreign non-governmental organizations (NGOs) that seek assistance under the Foreign Assistance Act of 1961. Here are the key points of what the bill proposes:
Prohibition of Restrictive Eligibility Requirements
The bill stipulates that foreign NGOs shall not be deemed ineligible for assistance if they provide certain health or medical services with funds that are not sourced from the U.S. government, provided that these services are compliant with local laws. This means that as long as the services provided are legal in the country of operation, the organizations can receive support regardless of using non-U.S. government funds.
Guidelines on Advocacy and Lobbying Activities
Additionally, the bill indicates that foreign NGOs will not face specific requirements regarding the use of non-U.S. government funds for advocacy and lobbying. The intention here is to align the requirements for foreign NGOs more closely with those that apply to domestic non-governmental organizations in the U.S. that receive similar assistance.
Impact on Health and Services Provided
This legislation is designed to potentially broaden the scope of services that foreign NGOs can provide, particularly in health care and related fields, without the fear of losing eligibility for assistance based solely on the use of their own funds for specific non-compliant services. It can facilitate access to broader health services for populations in need, especially in areas affected by restrictive funding policies.
Potential Benefits for Foreign NGOs
By easing these eligibility requirements, the bill could enhance the operational capabilities of NGOs working in various sectors, allowing them more flexibility in how they manage their funding and the services they offer. This might include a wider range of counseling and referral services that address health issues which may be sensitive or controversial.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
133 bill sponsors
-
Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
Actions
2 actions
Date | Action |
---|---|
Jan. 28, 2025 | Introduced in House |
Jan. 28, 2025 | Referred to the House Committee on Foreign Affairs. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.